EMA recommends Merck's COVID antiviral molnupiravir for those at risk of severe illness
20 November 2021 - 5:06AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2023 to Apr 2024